GoldenGolden
JDRF T1D Fund

JDRF T1D Fund

JDRF T1D Fund is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities.

JDRF T1D Fund is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities. The firm was launched in 2016 and is solely focused on T1D investments. The firm looks to provide equity investments in companies developing T1D products. Their portfolio consists of therapeutics, devices, vaccines, and diagnostics.

The firm has invested in fifteen companies, and holds $70 million in assets, and has helped raised over $200 million for their portfolio.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
SQZ Biotech

SQZ Biotech is a biotechnology company using their cell engineering platform for developing cell therapies for treating immune disorders.

Pandion Therapeutics is a Cambridge, Massachusetts-based company developing modular proteins, antibodies and bispecifics for autoimmune and inflammatory diseases.

Veralox Therapeutics is a small molecule drug discovery and development firm based in the Frederick Innovative Technology Center, Inc.

Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.

Sonoma Biotherapeutics is an autoimmune disease company.

A biotechnology company developing therapies and personalized diagnostics for celiac disease

Inversago Pharma is a Montreal-based company.

Seraxis is a Germantown, Anne Arundel County, Maryland-based company founded in 2013.

Diasome Pharmaceuticals is a Cleveland-based company.

14 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
April 20, 2021
BioSpace
Code Biotherapeutics Launches with $10 Million in Seed Financing to Develop Therapies for Debilitating Genetic Diseases - read this article along with other careers information, tips and advice on BioSpace
FinSMEs
June 16, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.